Welcome to our dedicated page for UB BANCORP news (Ticker: UBNC), a resource for investors and traders seeking the latest updates and insights on UB BANCORP stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect UB BANCORP's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of UB BANCORP's position in the market.
UB Bancorp (OTCQX: UBNC) reported a record net income of $1.9 million, or $0.32 per common share, for Q4 2020, reflecting a rise from $1.8 million in the same period last year. The Company increased its allowance for loan losses by $595,000 amid the pandemic's challenges. Core deposits grew significantly by $119.9 million (19.1%). Total assets reached $987.3 million, a 20.2% increase YoY. The Bank's asset quality remains strong, with non-performing assets at 0.36% of total assets. A cash dividend was paid to shareholders, and share repurchase approval was announced.